Company insight
Avocados join the fight against osteoarthritis
The market for joint health products continues to grow each year. Bioriginal has found a natural, sustainable way of contributing to the market in the form of AvoVida, a plant-based joint pain relief solution that comes from avocado oils.
I
n recent years, the world has turned towards nutritional solutions targeted at health and wellness. With a surge in ageing population worldwide, one of the main health concerns has been maintaining joint health. This, coupled with the emphasis Covid-19, has laid on the importance of health and nutrition and led to a preference for natural, plant- based and sustainable solutions. The market for joint health products is set to grow by 6.6% year-on-year from 2019 to 2024. While animal-derived options are common in the market – namely collagen, glucosamine and chondroitin sulfate – there is scope for a “greener” plant-based product in the form of Bioriginal’s uniquely branded AvoVida. AvoVida is a mixture of an unsaponifiable layer of fats extracted from avocado and soya in a one to two ratio. Scientific studies done on this combination of phytosterols has shown that there are proven benefits in reducing localised osteoarthritis (OA) inflammation. It is also important to note that phytosterols cannot be inherently produced by the human body, as with cholesterol, and have to be obtained through
balanced nutrition and the intake of supplements.
Sustainable alternatives Unlike its animal-derived counterparts, AvoVida is a vegan and non-GMO product that is manufactured using minimal processing. Bioriginal uses upcycling, whereby the starting material is taken from leftover flesh from the avocado kernels, which are an industry by-product. The avocado kernels and soya beans are mechanically pressed to remove the oil fraction. The latter then undergoes an alkali saponification treatment in order to extract the unsaponifiable layer. The phytosterols fractions are standardised in a 1:2 ratio and this blend
pain signalling pathway through its action on prostalglandin E2 (PGE2), and also regenerate cartilage and connective tissue in joints. These are both commonly characterised symptoms in people suffering from OA.
Avocado pain relief PGE2 is a signalling molecule involved in inflammation and pain, and a decrease in PGE2 usually also leads an increase in COX2 inhibitors.
High levels of COX2 inhibitors in the human body are known to increase the incidence of strokes and heart attacks. AvoVida, however, leads to the decrease of PGE2, without impacting the COX2 pathway.
Bioriginal offers customised solutions to its partners in the industry.
is then spray dried into a powder. AvoVida consists of 30% phytosterols. These specific phytosterols are mainly campersterol, beta- sitosterol and stigmasterol. Scientific studies have shown that AvoVida leads to decreased inflammation through the inhibition of interleukins (which are by nature pro- inflammatory). Through five conducted clinical trials, AvoVida has shown to decrease the
The material used for AvoVida is taken from the flesh of avocado kernels, an industry by-product. Ingredients Insight /
www.ingredients-insight.com
About Bioriginal As part of the Cooke Aqua Group, the business has roots
in the nutraceutical business that date back 25 years. The company’s mission is to create healthy and sustainable nutritional solutions that are good for people and the planet. Its portfolio includes marine oils, plant-based oils, plant based proteins and a variety of branded botanicals.
Bioriginal prides itself in anticipating market trends and providing customised solutions to its partners in the industry. It offers AvoVida, not only as a stand alone ingredient, but in a range of emulsions as well as in several capsules, which are combined with other vitamins and minerals. ●
www.bioriginal.nl 55
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112
